Refining the risk of htlv-1-associated myelopathy in people living with htlv-1: identification of a ham-like phenotype in a proportion of asymptomatic carriers

HIGHLIGHTS

• who: Daniel Harding from the Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mu00f6lndal, Sweden have published the article: Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers, in the Journal: (JOURNAL)
• what: Excel 2016 with the Analysis ToolPak Add-In (Microsoft, Redmond, WA, USA) were used to perform statistical analyses and plot graphs. This study identified markers that differentiate patients with HAM from HTLV-1 ACs, but more importantly, it shows that the proposed markers can identify a A . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.